trending Market Intelligence /marketintelligence/en/news-insights/trending/9ork03okxH32p4l1XOd2fw2 content esgSubNav
In This List

Soleno Therapeutics to implement 1-for-5 reverse stock split

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


Soleno Therapeutics to implement 1-for-5 reverse stock split

Soleno Therapeutics, Inc. said it will implement a 1-for-5 reverse stock split of its outstanding common shares on Oct. 6.

Soleno Therapeutics' common shares will trade on a split-adjusted basis starting Oct. 6. Following the split, the company's outstanding and issued common shares will be reduced to about 10.4 million.

The company said the reverse stock split could help it regain compliance with Nasdaq's bid price requirement for continued listing.